硫酸化氧甾醇作为治疗非酒精性脂肪性肝病的候选药物。 - Suppr

Suppr

超能文献

Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease.

作者信息

Polyzos Stergios A, Kountouras Jannis, Mantzoros Christos S

出版信息

Metabolism. 2012 Jun;61(6):755-8. doi: 10.1016/j.metabol.2012.01.020. Epub 2012 Mar 3.

DOI:10.1016/j.metabol.2012.01.020

PMID:22386938

Abstract

摘要

相似文献

Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease.

Metabolism. 2012 Jun;61(6):755-8. doi: 10.1016/j.metabol.2012.01.020. Epub 2012 Mar 3.

Sulfated oxysterol 25HC3S as a therapeutic target of non-alcoholic fatty liver disease.

Metabolism. 2012 Aug;61(8):1055-7. doi: 10.1016/j.metabol.2012.04.011. Epub 2012 May 15.

Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.

Metabolism. 2012 Jun;61(6):836-45. doi: 10.1016/j.metabol.2011.11.014. Epub 2012 Jan 5.

Liver X receptors bridge hepatic lipid metabolism and inflammation.

J Dig Dis. 2012 Feb;13(2):69-74. doi: 10.1111/j.1751-2980.2011.00554.x.

Signalling mechanisms linking hepatic glucose and lipid metabolism.

Diabetologia. 2006 Aug;49(8):1732-41. doi: 10.1007/s00125-006-0295-3. Epub 2006 May 23.

[Expression and significance of liver X receptor-alpha in nonalcoholic fatty liver disease in rats].

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Aug;23(4):265-8.

Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.

Br J Nutr. 2017 Dec;118(11):914-929. doi: 10.1017/S000711451700232X. Epub 2017 Nov 27.

The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.

Semin Liver Dis. 2010 Nov;30(4):378-90. doi: 10.1055/s-0030-1267538. Epub 2010 Oct 19.

Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.

Am J Physiol Endocrinol Metab. 2011 May;300(5):E886-93. doi: 10.1152/ajpendo.00332.2010. Epub 2011 Mar 1.

Effect of an Ilex asprella root decoction on the related genes of lipid metabolism from chronic stress and hyperlipidemic fatty liver in rats.

Chin Med J (Engl). 2012 Oct;125(19):3539-42.

引用本文的文献

Larsucosterol: endogenous epigenetic regulator for treating chronic and acute liver diseases.

Am J Physiol Endocrinol Metab. 2024 May 1;326(5):E577-E587. doi: 10.1152/ajpendo.00406.2023. Epub 2024 Feb 21.

The Regulation of Steroid Action by Sulfation and Desulfation.

Endocr Rev. 2015 Oct;36(5):526-63. doi: 10.1210/er.2015-1036. Epub 2015 Jul 27.

Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation.

Am J Physiol Endocrinol Metab. 2014 Jan 15;306(2):E123-30. doi: 10.1152/ajpendo.00552.2013. Epub 2013 Dec 3.

5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.

Mol Pharmacol. 2013 Mar;83(3):648-58. doi: 10.1124/mol.112.081505. Epub 2012 Dec 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验